Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

159 та иш

Иш: The role of TLRs (microbe recognition receptor) in gastric cancer: An update

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

    Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel +4

    МақолаGlobal Cancer Incidence and ScreeningCA A Cancer Journal for Clinicians202160 иқтибос
    ABI

  2. The blockade of immune checkpoints in cancer immunotherapy

    Drew M. Pardoll

    Шарҳ мақола20127 иқтибос
    ABI

  3. Cancer-related inflammation

    Alberto Mantovani, Paola Allavena, Antonio Sica +1

    Шарҳ мақола20085 иқтибос
    ABI

  4. Burden of Gastric Cancer

    Aaron P. Thrift, Hashem B. El‐Serag

    Шарҳ мақола20194 иқтибос
    ABI

  5. Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention

    Parisa Karimi, Farhad Islami, Sharmila Anandasabapathy +2

    Шарҳ мақола20144 иқтибос
    ABI

  6. Gastric cancer

    Elizabeth Smyth, Magnus Nilsson, Heike I. Grabsch +2

    Шарҳ мақола20204 иқтибос
    ABI

  7. Inflammation and Cancer: Triggers, Mechanisms, and Consequences

    Florian R. Greten, Sergei I. Grivennikov

    Шарҳ мақола20193 иқтибос
    ABI

  8. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in <i>Tlr4</i> Gene

    Alexander Poltorak, Xiaolong He, Irina Smirnova +11

    Мақола19983 иқтибос
    ABI

  9. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

    Pelayo Correa

    Мақола19923 иқтибос
    ABI

  10. Epidemiology of gastric cancer: global trends, risk factors and prevention

    Prashanth Rawla, Adam Barsouk

    Шарҳ мақола20192 иқтибос
    ABI

  11. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors

    Satya Das, Douglas B. Johnson

    Шарҳ мақола20192 иқтибос
    ABI

  12. The cancer-immunity cycle: Indication, genotype, and immunotype

    Ira Mellman, Daniel S. Chen, Thomas Powles +1

    Шарҳ мақола20232 иқтибос
    ABI

  13. Inflammation and cancer

    Nitin K. Singh, Deepak Baby, Jagadish Prasad Rajguru +3

    Шарҳ мақола20192 иқтибос
    ABI

  14. The Role of TLRs in Anti-cancer Immunity and Tumor Rejection

    Zuzanna Urban‐Wójciuk, Mohd M. Khan, Benjamin L. Oyler +5

    Шарҳ мақола20192 иқтибос
    ABI

  15. Toll‐Like Receptors

    Kiyoshi Takeda, Shizuo Akira

    Мақола20152 иқтибос
    ABI

  16. Characteristics of gastric cancer around the world

    María José López, Junior Carbajal, Alejandro Alfaro +10

    Шарҳ мақола20222 иқтибос
    ABI

  17. Pathogen Recognition and Innate Immunity

    Shizuo Akira, Satoshi Uematsu, Osamu Takeuchi

    Шарҳ мақола20062 иқтибос
    ABI

  18. The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses

    Spyros A. Kalams, Bruce D. Walker

    Шарҳ мақола19982 иқтибос
    ABI

  19. Interleukin 6 gene polymorphism ‐174 is associated with the diffuse type gastric carcinoma

    Vesa‐Matti Pohjanen, Olli‐Pekka Koivurova, Johanna M. Mäkinen +7

    Мақола20132 иқтибос
    ABI

  20. Comprehensive molecular characterization of gastric adenocarcinoma

    Adam J. Bass, Natalie Tasman, Brady Bernard +94

    Мақола20142 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI